Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access

INTRODUCTION: Access to pimavanserin, the only Parkinson disease–related psychosis treatment approved by the FDA, is restricted by insurance requirements, a limited distribution network, and high costs. Following initiation, patients require monitoring for safety and effectiveness. The primary objec...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ment Health Clin
Main Authors: Livezey, Sabrina, Shah, Nisha B., McCormick, Robert, DeClercq, Josh, Choi, Leena, Zuckerman, Autumn D.
Format: Artigo
Sprog:Inglês
Udgivet: College of Psychiatric & Neurologic Pharmacists 2021
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8120983/
https://ncbi.nlm.nih.gov/pubmed/34026394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2021.05.187
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker